Gwenn Hansen Nurix Therapeutics, Inc. (NRIX) insider trading activity

Gwenn Hansen is Chief Scientific Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 50,670 shares of NRIX, which is worth approximately $991,611. The most recent transaction as insider was on Dec 01, 2021, when has been sold 400 shares (Common Stock) at a price of $7.26 per share, resulting in proceeds of $2,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.7K

12.23% 3M change

51.12% 12M change

Total Value Held $991,611

Gwenn Hansen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.67%	14,597 Common Stock
Nov 01 2021	SELL Open market or private sale	$13,296 $33.24 p/Share	400 Reduced 2.74%	14,197 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.67%	14,597 Common Stock
Oct 27 2021	SELL Open market or private sale	$14,000 $35.0 p/Share	400 Reduced 2.74%	14,197 Common Stock
Oct 27 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.67%	14,597 Common Stock
Oct 01 2021	SELL Open market or private sale	$11,968 $29.92 p/Share	400 Reduced 2.74%	14,197 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.67%	14,597 Common Stock
Sep 07 2021	SELL Open market or private sale	$56,000 $35.0 p/Share	1,600 Reduced 10.13%	14,197 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$11,616 $7.26 p/Share	1,600 Added 9.2%	15,797 Common Stock
Sep 01 2021	SELL Open market or private sale	$12,936 $32.34 p/Share	400 Reduced 2.74%	14,197 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.67%	14,597 Common Stock
Aug 02 2021	SELL Open market or private sale	$12,484 $31.21 p/Share	400 Reduced 2.82%	13,804 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.74%	14,204 Common Stock
Jul 01 2021	SELL Open market or private sale	$10,704 $26.76 p/Share	400 Reduced 2.82%	13,804 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.74%	14,204 Common Stock
Jun 01 2021	SELL Open market or private sale	$11,096 $27.74 p/Share	400 Reduced 2.82%	13,804 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.74%	14,204 Common Stock
May 03 2021	SELL Open market or private sale	$27,992 $34.99 p/Share	800 Reduced 5.48%	13,804 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$5,808 $7.26 p/Share	800 Added 5.19%	14,604 Common Stock
Apr 05 2021	SELL Open market or private sale	$14,000 $35.0 p/Share	400 Reduced 2.82%	13,804 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.74%	14,204 Common Stock
Apr 01 2021	SELL Open market or private sale	$12,620 $31.55 p/Share	400 Reduced 2.82%	13,804 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$2,904 $7.26 p/Share	400 Added 2.74%	14,204 Common Stock
Mar 16 2021	SELL Open market or private sale	$36,000 $45.0 p/Share	800 Reduced 5.48%	13,804 Common Stock
Mar 16 2021	BUY Exercise of conversion of derivative security	$5,808 $7.26 p/Share	800 Added 5.19%	14,604 Common Stock

Gwenn Hansen

Chief Scientific Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account